HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia.

Abstract
Acquired neuromyotonia (ANM) is associated with antibodies to voltage-gated K+ channels (VGKCs). ANM sera reduce the number of K+ currents in neuronal cell lines, but it is not clear how the antibodies act. Here, we show by using the NB-1 cell line that the reduction in K+ currents by IgG is independent of added complement. IgG Fc and Fab fragments from ANM sera had no effect, but three of four ANM F(ab')2 fragments significantly reduced K+ currents. Thus, cross-linking of the channels by divalent antibodies is likely to be an important mechanism in reducing K+ currents.
AuthorsHisanori Tomimitsu, Kimiyoshi Arimura, Tatsui Nagado, Osamu Watanabe, Reika Otsuka, Asutsugu Kurono, Yoshito Sonoda, Mitsuhiro Osame, Masaki Kameyama
JournalAnnals of neurology (Ann Neurol) Vol. 56 Issue 3 Pg. 440-4 (Sep 2004) ISSN: 0364-5134 [Print] United States
PMID15349875 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Immunoglobulin G
  • Potassium Channels, Voltage-Gated
Topics
  • Adult
  • Autoantibodies (pharmacology)
  • Cell Line, Tumor
  • Female
  • Humans
  • Immunoglobulin G (metabolism, pharmacology)
  • Isaacs Syndrome (immunology, metabolism)
  • Male
  • Middle Aged
  • Potassium Channels, Voltage-Gated (antagonists & inhibitors, immunology, metabolism)
  • Statistics, Nonparametric

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: